$258.15
Price
$456.2B
Market Cap
72.7
P/E Ratio
15.9
Forward P/E
$3.55
EPS (TTM)
2.63%
Dividend Yield
$6.6B
Cash
$67.5B
Total Debt
1.77B
Shares Out
$190.75
$267.47
52-Week Range
Institutional Ownership of Abbvie Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 12.4K | $3M | — | — | ||
| 2.4K | $608969 | — | — |
Trading Activity for Abbvie Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q4 | |||||
| SELL | -0.8% | 12.4K | $2M | $181.77 | |
| 2024-Q2 | |||||
| SELL | EXIT | — | — | $165.44 | |
| 2024-Q1 | |||||
| SELL | -47.0% | 213.6K | $39M | $175.01 | |
| 2023-Q4 | |||||
| BUY | +1.4% | 402.9K | $62M | $146.23 | |
| SELL | -0.6% | 12.5K | $2M | $146.23 | |
| 2023-Q3 | |||||
| BUY | +17.1% | 397.2K | $59M | $148.91 | |
| SELL | -0.1% | 12.6K | $2M | $148.91 | |
| SELL | EXIT | — | — | $148.91 | |
| 2023-Q2 | |||||
| BUY | NEW | 339.1K | $46M | $145.11 | |
| SELL | -0.1% | 12.6K | $2M | $145.11 | |
| 2023-Q1 | |||||
| SELL | -14.3% | 1.8K | $286866 | $152.71 | |
| 2022-Q4 | |||||
| SELL | -12.5% | 2.1K | $339381 | $152.51 | |
| 2022-Q2 | |||||
| SELL | -2.3% | 12.6K | $2M | $152.09 | |
| 2022-Q1 | |||||
| SELL | EXIT | — | — | $144.03 | |
| SELL | -40.0% | 2.4K | $389000 | $144.03 | |
| 2021-Q4 | |||||
| SELL | -78.9% | 3.0M | $411M | $116.63 | |
| 2021-Q3 | |||||
| SELL | -29.9% | 14.4M | $1.6B | $115.73 | |
| SELL | EXIT | — | — | $115.73 | |
| BUY | +2.4% | 12.9K | $1M | $115.73 | |
| SELL | -9.1% | 4.0K | $431000 | $115.73 | |
| 2021-Q2 | |||||
| SELL | -10.2% | 20.5M | $2.3B | $113.06 | |
| SELL | -0.3% | 390.4K | $44M | $113.06 | |
| 2021-Q1 | |||||
| SELL | -10.4% | 22.9M | $2.5B | $106.72 | |
| SELL | -0.2% | 391.6K | $42M | $106.72 | |
| 2020-Q4 | |||||
| BUY | +20.1% | 25.5M | $2.7B | $98.72 | |
| BUY | +29.7% | 392.2K | $42M | $98.72 | |
| 2020-Q3 | |||||
| BUY | NEW | 21.3M | $1.9B | $94.68 | |
| BUY | +46.8% | 302.3K | $26M | $94.68 | |
| BUY | +0.1% | 12.6K | $1M | $94.68 | |
| 2020-Q2 | |||||
| BUY | NEW | 206.0K | $20M | $90.00 | |
| BUY | +0.7% | 12.6K | $1M | $90.00 | |
| 2020-Q1 | |||||
| SELL | -2.3% | 12.5K | $953000 | $87.57 | |
| 2019-Q4 | |||||
| SELL | -1.5% | 12.8K | $1M | $86.05 | |
| 2019-Q1 | |||||
| SELL | -6.8% | 13.0K | $1M | $80.29 | |
| SELL | EXIT | — | — | $80.29 | |
| 2018-Q2 | |||||
| BUY | +1.9% | 14.0K | $1M | $98.61 | |
| 2018-Q1 | |||||
| SELL | -2.8% | 13.7K | $1M | $112.22 | |
Insider Trading for Abbvie Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.